ResMed (ASX: RMD) Shares Fall Amid Competitive Pressure From Emerging OSA Drug Candidate

ResMed Inc. (ASX: RMD) based in San Diego, is a global medical device company listed on the NYSE and ASX, specializing in sleep apnoea therapy and digital respiratory health solutions. The Shares of ResMed Inc. (ASX: RMD) declined 5% to A$36.90 on Tuesday after …

Team Kalkine | 20 May 2025| Read Time : 10 Mins

James Hardie (ASX: JHX) Shares Edge Higher Ahead of Q4 Results; UBS Cuts EPS Forecasts and Price Target

James Hardie Industries (ASX: JHX)is a global building materials company focused on fiber cement products, with key markets in the U.S., Australia, and Europe. The Shares of James Hardie Industries (ASX: JHX) rose modestly by 0.7% on Monday to A$38.61 ahead of the company’s …

Team Kalkine | 20 May 2025| Read Time : 10 Mins

Rio Tinto Expands Lithium Portfolio with AU$1.4Bn Chile Joint Venture

Highlights

Team Kalkine | 20 May 2025| Read Time : 10 Mins

TechnologyOne Shares Rocket as Profit and Dividend Reach New Highs

Highlights

Team Kalkine | 20 May 2025| Read Time : 10 Mins

Kogan Shares Slump on Tuesday Over Declining Profits

Highlights

Team Kalkine | 20 May 2025| Read Time : 10 Mins

Australian Market Rises on Rate Cut Hopes; CBA Hits Record High

The S&P/ASX 200 Index rose 0.74% in early trade, led by financial and tech stocks.

Team Kalkine | 20 May 2025| Read Time : 10 Mins

Macquarie Cuts Price Target on Fletcher Building (ASX: FBU)

Fletcher Building Ltd (ASX: FBU)has faced a turbulent start to 2025 despite a modest year-to-date share price recovery. It is trading at AU$3.04, which slipped from recent highs of around AU$3.14, and analysts remain sceptical about its outlook. A series of broker downgrades highlights …

Team Kalkine | 19 May 2025| Read Time : 10 Mins